Copyright
©The Author(s) 2025.
World J Hepatol. Jun 27, 2025; 17(6): 106481
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.106481
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.106481
Table 1 Demographics and clinicopathological characteristics of study cohort, n (%)
| Parameter | Control (n = 12) | Metabolic dysfunction-associated steatotic liver disease (n = 14) | Hepatocellular carcinoma (n = 19) |
| Age (years) (mean ± SD) | 60.9 ± 13.3 | 59.9 ± 8.0 | 74.4 ± 7.6 |
| Sex | |||
| Male | 5 (41.7) | 9 (64.3) | 12 (63.2) |
| Female | 7 (58.3) | 5 (35.7) | 7 (36.8) |
| Race/ethnicity | |||
| African-American/Black | 9 (75.0) | 4 (28.6) | 8 (42.1) |
| Asian | 2 (16.7) | 7 (50.0) | 3 (15.8) |
| White/Caucasian | 1 (8.3) | 2 (14.3) | 8 (42.1) |
| Other race | 0 (0.0) | 1 (7.1) | 0 (0.0) |
| Hispanic | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Fibrosis stage | |||
| S0-2 | 9 (64.3) | ||
| S3-4 | 5 (35.7) | ||
| Tumor stage | |||
| TX T0-1 | 13 (68.4) | ||
| T2-3 | 5 (26.3) | ||
| Unknown | 1 (5.3) |
- Citation: Siguencia F, Matsuda M, Pandyarajan V, Tanaka S, Smith SM, Bresee C, Seki E, Rosser CJ, Furuya H. Diagnostic performance of Liver FibraChek Dx©, a blood-based test for the non-invasive detection of liver cirrhosis and cancer. World J Hepatol 2025; 17(6): 106481
- URL: https://www.wjgnet.com/1948-5182/full/v17/i6/106481.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i6.106481